Studies have shown that compound 968 inhibits the growth of ovarian cancer cells by inducing cell cycle arrest of G1-phase, cell apoptosis, and cellular stress, suggesting that targeting GLS1 is a therapeutic strategy for ovarian cancer (46). Here, GLS is linked to ovarian carcinoma.